Structure

Physi-Chem Properties

Molecular Weight:  428.33
Volume:  477.08
LogP:  5.937
LogD:  5.572
LogS:  -5.614
# Rotatable Bonds:  5
TPSA:  54.37
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.585
Synthetic Accessibility Score:  4.879
Fsp3:  0.857
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.76
MDCK Permeability:  1.6872150808922015e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.008
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.993
30% Bioavailability (F30%):  0.952

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.778
Plasma Protein Binding (PPB):  94.57196807861328%
Volume Distribution (VD):  0.734
Pgp-substrate:  1.473222017288208%

ADMET: Metabolism

CYP1A2-inhibitor:  0.092
CYP1A2-substrate:  0.583
CYP2C19-inhibitor:  0.393
CYP2C19-substrate:  0.922
CYP2C9-inhibitor:  0.688
CYP2C9-substrate:  0.335
CYP2D6-inhibitor:  0.011
CYP2D6-substrate:  0.111
CYP3A4-inhibitor:  0.875
CYP3A4-substrate:  0.843

ADMET: Excretion

Clearance (CL):  7.433
Half-life (T1/2):  0.364

ADMET: Toxicity

hERG Blockers:  0.431
Human Hepatotoxicity (H-HT):  0.36
Drug-inuced Liver Injury (DILI):  0.57
AMES Toxicity:  0.014
Rat Oral Acute Toxicity:  0.071
Maximum Recommended Daily Dose:  0.096
Skin Sensitization:  0.894
Carcinogencity:  0.374
Eye Corrosion:  0.185
Eye Irritation:  0.193
Respiratory Toxicity:  0.97

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC103051

Natural Product ID:  NPC103051
Common Name*:   Stoloniferone E
IUPAC Name:   (6R,8S,9S,10R,11R,13R,14S,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-6,11-dihydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-one
Synonyms:   stoloniferone E
Standard InCHIKey:  RYMHLKHGLSCOPD-BONNHHEPSA-N
Standard InCHI:  InChI=1S/C28H44O3/c1-16(2)17(3)10-11-18(4)20-12-13-21-19-14-23(29)22-8-7-9-25(31)28(22,6)26(19)24(30)15-27(20,21)5/h7-9,16-21,23-24,26,29-30H,10-15H2,1-6H3/t17-,18+,19-,20+,21-,23+,24+,26+,27+,28+/m0/s1
SMILES:  C[C@H](C(C)C)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)C[C@@H](O)[C@H]1[C@H]2C[C@H](C2=CC=CC(=O)[C@]12C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL491589
PubChem CID:   11122837
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003567] Ergostane steroids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3077 Clavularia viridis Species Clavulariidae Eukaryota n.a. Okinawan n.a. PMID[11720524]
NPO3077 Clavularia viridis Species Clavulariidae Eukaryota n.a. Formosan soft corals n.a. PMID[12444673]
NPO33409 clavularia violacea Species Clavulariidae Eukaryota n.a. Formosan soft corals n.a. PMID[12444673]
NPO3077 Clavularia viridis Species Clavulariidae Eukaryota n.a. Taiwanese octocoral n.a. PMID[15104481]
NPO3077 Clavularia viridis Species Clavulariidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 3.2 10'-4 ug/ml PMID[504516]
NPT139 Cell Line HT-29 Homo sapiens ED50 = 9.1 10'-3 ug/ml PMID[504516]
NPT168 Cell Line P388 Mus musculus ED50 = 1.2 10'-4 ug/ml PMID[504516]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC103051 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9457 High Similarity NPC271195
0.914 High Similarity NPC299100
0.913 High Similarity NPC233116
0.913 High Similarity NPC475806
0.9121 High Similarity NPC473999
0.9121 High Similarity NPC309603
0.9062 High Similarity NPC154072
0.9043 High Similarity NPC180950
0.9022 High Similarity NPC48010
0.898 High Similarity NPC247957
0.898 High Similarity NPC249187
0.8947 High Similarity NPC301534
0.8947 High Similarity NPC250757
0.8936 High Similarity NPC8993
0.8936 High Similarity NPC209662
0.8936 High Similarity NPC474690
0.8925 High Similarity NPC272746
0.8925 High Similarity NPC473998
0.8901 High Similarity NPC141292
0.8878 High Similarity NPC293753
0.8854 High Similarity NPC108078
0.8842 High Similarity NPC259286
0.883 High Similarity NPC69454
0.883 High Similarity NPC474736
0.883 High Similarity NPC134826
0.8804 High Similarity NPC310752
0.8804 High Similarity NPC292491
0.88 High Similarity NPC257353
0.8791 High Similarity NPC472986
0.8791 High Similarity NPC472985
0.875 High Similarity NPC249954
0.8737 High Similarity NPC111015
0.8737 High Similarity NPC245972
0.8737 High Similarity NPC196485
0.8723 High Similarity NPC63748
0.871 High Similarity NPC119416
0.871 High Similarity NPC186688
0.87 High Similarity NPC209502
0.87 High Similarity NPC72255
0.87 High Similarity NPC204833
0.8696 High Similarity NPC475740
0.8696 High Similarity NPC58063
0.8696 High Similarity NPC136548
0.8687 High Similarity NPC234892
0.8681 High Similarity NPC471224
0.8681 High Similarity NPC470574
0.866 High Similarity NPC474785
0.866 High Similarity NPC320306
0.866 High Similarity NPC99726
0.866 High Similarity NPC474938
0.8646 High Similarity NPC297199
0.8632 High Similarity NPC109305
0.8617 High Similarity NPC191684
0.8617 High Similarity NPC126993
0.8617 High Similarity NPC85173
0.8614 High Similarity NPC260268
0.8614 High Similarity NPC49958
0.8614 High Similarity NPC302607
0.8614 High Similarity NPC48733
0.8614 High Similarity NPC171137
0.8614 High Similarity NPC152695
0.8614 High Similarity NPC202167
0.8614 High Similarity NPC85829
0.8614 High Similarity NPC296945
0.8614 High Similarity NPC476027
0.8614 High Similarity NPC97202
0.8614 High Similarity NPC50692
0.8614 High Similarity NPC150531
0.8614 High Similarity NPC214264
0.8614 High Similarity NPC319077
0.8614 High Similarity NPC149047
0.8602 High Similarity NPC193360
0.8602 High Similarity NPC471722
0.8602 High Similarity NPC328539
0.8587 High Similarity NPC474733
0.8587 High Similarity NPC31564
0.8587 High Similarity NPC474732
0.8587 High Similarity NPC145879
0.8587 High Similarity NPC474778
0.8587 High Similarity NPC72133
0.8586 High Similarity NPC282524
0.8571 High Similarity NPC57079
0.8571 High Similarity NPC214043
0.8571 High Similarity NPC108368
0.8571 High Similarity NPC114274
0.8571 High Similarity NPC191565
0.8571 High Similarity NPC85774
0.8557 High Similarity NPC117133
0.8557 High Similarity NPC78473
0.8542 High Similarity NPC471207
0.8542 High Similarity NPC292793
0.8542 High Similarity NPC469406
0.8529 High Similarity NPC475060
0.8529 High Similarity NPC83744
0.8529 High Similarity NPC477916
0.8529 High Similarity NPC220229
0.8526 High Similarity NPC131872
0.8526 High Similarity NPC212948
0.8511 High Similarity NPC275740
0.8511 High Similarity NPC86319
0.8511 High Similarity NPC31985
0.8511 High Similarity NPC1015
0.8511 High Similarity NPC472973
0.8511 High Similarity NPC262858
0.8511 High Similarity NPC472240
0.8511 High Similarity NPC2983
0.85 High Similarity NPC477915
0.8495 Intermediate Similarity NPC93778
0.8495 Intermediate Similarity NPC287079
0.8485 Intermediate Similarity NPC327431
0.8485 Intermediate Similarity NPC266955
0.8478 Intermediate Similarity NPC474083
0.8469 Intermediate Similarity NPC253826
0.8469 Intermediate Similarity NPC122294
0.8454 Intermediate Similarity NPC127063
0.8447 Intermediate Similarity NPC217201
0.8447 Intermediate Similarity NPC329417
0.8438 Intermediate Similarity NPC475255
0.8438 Intermediate Similarity NPC214697
0.8438 Intermediate Similarity NPC472930
0.8431 Intermediate Similarity NPC166607
0.8421 Intermediate Similarity NPC69622
0.8416 Intermediate Similarity NPC311612
0.8404 Intermediate Similarity NPC471724
0.8404 Intermediate Similarity NPC143767
0.8404 Intermediate Similarity NPC474677
0.8404 Intermediate Similarity NPC131470
0.84 Intermediate Similarity NPC476240
0.84 Intermediate Similarity NPC115899
0.84 Intermediate Similarity NPC472924
0.84 Intermediate Similarity NPC476223
0.84 Intermediate Similarity NPC224720
0.8387 Intermediate Similarity NPC118648
0.8387 Intermediate Similarity NPC475022
0.8387 Intermediate Similarity NPC469994
0.8387 Intermediate Similarity NPC222613
0.8384 Intermediate Similarity NPC16021
0.8384 Intermediate Similarity NPC235464
0.8384 Intermediate Similarity NPC166745
0.8384 Intermediate Similarity NPC48647
0.8381 Intermediate Similarity NPC474315
0.837 Intermediate Similarity NPC59453
0.837 Intermediate Similarity NPC33913
0.837 Intermediate Similarity NPC472265
0.837 Intermediate Similarity NPC473246
0.837 Intermediate Similarity NPC221758
0.8367 Intermediate Similarity NPC7124
0.8367 Intermediate Similarity NPC472941
0.8367 Intermediate Similarity NPC456
0.8365 Intermediate Similarity NPC214644
0.8365 Intermediate Similarity NPC11710
0.8351 Intermediate Similarity NPC279410
0.8351 Intermediate Similarity NPC49670
0.8351 Intermediate Similarity NPC119562
0.835 Intermediate Similarity NPC472925
0.835 Intermediate Similarity NPC185
0.8333 Intermediate Similarity NPC185936
0.8333 Intermediate Similarity NPC160843
0.8333 Intermediate Similarity NPC472978
0.8333 Intermediate Similarity NPC19114
0.8333 Intermediate Similarity NPC168027
0.8317 Intermediate Similarity NPC473424
0.8317 Intermediate Similarity NPC136289
0.8317 Intermediate Similarity NPC87351
0.8316 Intermediate Similarity NPC84271
0.8316 Intermediate Similarity NPC268406
0.8316 Intermediate Similarity NPC102414
0.8316 Intermediate Similarity NPC477943
0.8316 Intermediate Similarity NPC472983
0.8316 Intermediate Similarity NPC77168
0.8316 Intermediate Similarity NPC146554
0.8316 Intermediate Similarity NPC26959
0.8316 Intermediate Similarity NPC472971
0.8316 Intermediate Similarity NPC472970
0.83 Intermediate Similarity NPC144660
0.83 Intermediate Similarity NPC299971
0.83 Intermediate Similarity NPC470074
0.83 Intermediate Similarity NPC287833
0.83 Intermediate Similarity NPC307954
0.83 Intermediate Similarity NPC476274
0.8298 Intermediate Similarity NPC475772
0.8298 Intermediate Similarity NPC474684
0.8298 Intermediate Similarity NPC142361
0.8286 Intermediate Similarity NPC76084
0.8283 Intermediate Similarity NPC161147
0.8283 Intermediate Similarity NPC126815
0.828 Intermediate Similarity NPC469948
0.828 Intermediate Similarity NPC476426
0.828 Intermediate Similarity NPC474218
0.8273 Intermediate Similarity NPC476962
0.8269 Intermediate Similarity NPC65941
0.8265 Intermediate Similarity NPC476174
0.8265 Intermediate Similarity NPC280725
0.8265 Intermediate Similarity NPC476245
0.8265 Intermediate Similarity NPC88310
0.8252 Intermediate Similarity NPC266570
0.8252 Intermediate Similarity NPC189863
0.8247 Intermediate Similarity NPC250575
0.8247 Intermediate Similarity NPC474807
0.8247 Intermediate Similarity NPC12722

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC103051 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8925 High Similarity NPD6079 Approved
0.8791 High Similarity NPD3618 Phase 1
0.871 High Similarity NPD5328 Approved
0.837 Intermediate Similarity NPD4786 Approved
0.8367 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8367 Intermediate Similarity NPD5222 Approved
0.8367 Intermediate Similarity NPD5221 Approved
0.8317 Intermediate Similarity NPD5211 Phase 2
0.8283 Intermediate Similarity NPD5173 Approved
0.8247 Intermediate Similarity NPD4202 Approved
0.8191 Intermediate Similarity NPD5279 Phase 3
0.8182 Intermediate Similarity NPD4697 Phase 3
0.8172 Intermediate Similarity NPD3666 Approved
0.8172 Intermediate Similarity NPD3133 Approved
0.8172 Intermediate Similarity NPD3665 Phase 1
0.8155 Intermediate Similarity NPD5141 Approved
0.8152 Intermediate Similarity NPD3667 Approved
0.8119 Intermediate Similarity NPD5286 Approved
0.8119 Intermediate Similarity NPD5285 Approved
0.8119 Intermediate Similarity NPD4696 Approved
0.8039 Intermediate Similarity NPD5223 Approved
0.7961 Intermediate Similarity NPD5224 Approved
0.7961 Intermediate Similarity NPD5226 Approved
0.7961 Intermediate Similarity NPD5225 Approved
0.7961 Intermediate Similarity NPD4633 Approved
0.7941 Intermediate Similarity NPD7639 Approved
0.7941 Intermediate Similarity NPD7640 Approved
0.7921 Intermediate Similarity NPD4755 Approved
0.79 Intermediate Similarity NPD4629 Approved
0.79 Intermediate Similarity NPD5210 Approved
0.7885 Intermediate Similarity NPD5174 Approved
0.7885 Intermediate Similarity NPD5175 Approved
0.7843 Intermediate Similarity NPD7638 Approved
0.7838 Intermediate Similarity NPD7115 Discovery
0.7812 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD4634 Approved
0.7778 Intermediate Similarity NPD7515 Phase 2
0.7767 Intermediate Similarity NPD4700 Approved
0.7766 Intermediate Similarity NPD4221 Approved
0.7766 Intermediate Similarity NPD4223 Phase 3
0.7757 Intermediate Similarity NPD6899 Approved
0.7757 Intermediate Similarity NPD6881 Approved
0.7755 Intermediate Similarity NPD4753 Phase 2
0.7708 Intermediate Similarity NPD5329 Approved
0.7706 Intermediate Similarity NPD6649 Approved
0.7706 Intermediate Similarity NPD6650 Approved
0.77 Intermediate Similarity NPD6399 Phase 3
0.7664 Intermediate Similarity NPD5697 Approved
0.7629 Intermediate Similarity NPD5690 Phase 2
0.7629 Intermediate Similarity NPD4519 Discontinued
0.7629 Intermediate Similarity NPD4623 Approved
0.7629 Intermediate Similarity NPD4694 Approved
0.7629 Intermediate Similarity NPD5280 Approved
0.7615 Intermediate Similarity NPD6883 Approved
0.7615 Intermediate Similarity NPD7290 Approved
0.7615 Intermediate Similarity NPD7102 Approved
0.7604 Intermediate Similarity NPD4197 Approved
0.76 Intermediate Similarity NPD5281 Approved
0.76 Intermediate Similarity NPD5284 Approved
0.7593 Intermediate Similarity NPD4729 Approved
0.7593 Intermediate Similarity NPD5168 Approved
0.7593 Intermediate Similarity NPD4730 Approved
0.7593 Intermediate Similarity NPD6011 Approved
0.757 Intermediate Similarity NPD7128 Approved
0.757 Intermediate Similarity NPD6675 Approved
0.757 Intermediate Similarity NPD5739 Approved
0.757 Intermediate Similarity NPD6402 Approved
0.7568 Intermediate Similarity NPD4632 Approved
0.7547 Intermediate Similarity NPD4754 Approved
0.7545 Intermediate Similarity NPD6617 Approved
0.7545 Intermediate Similarity NPD6847 Approved
0.7545 Intermediate Similarity NPD6869 Approved
0.7545 Intermediate Similarity NPD8130 Phase 1
0.7526 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7523 Intermediate Similarity NPD6012 Approved
0.7523 Intermediate Similarity NPD6372 Approved
0.7523 Intermediate Similarity NPD6373 Approved
0.7523 Intermediate Similarity NPD6013 Approved
0.7523 Intermediate Similarity NPD6014 Approved
0.75 Intermediate Similarity NPD4788 Approved
0.7477 Intermediate Similarity NPD6882 Approved
0.7477 Intermediate Similarity NPD8297 Approved
0.7473 Intermediate Similarity NPD4058 Approved
0.7455 Intermediate Similarity NPD5251 Approved
0.7455 Intermediate Similarity NPD5250 Approved
0.7455 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD5249 Phase 3
0.7455 Intermediate Similarity NPD5248 Approved
0.7455 Intermediate Similarity NPD5247 Approved
0.7455 Intermediate Similarity NPD5169 Approved
0.7455 Intermediate Similarity NPD5135 Approved
0.7451 Intermediate Similarity NPD7748 Approved
0.7449 Intermediate Similarity NPD6684 Approved
0.7449 Intermediate Similarity NPD4690 Approved
0.7449 Intermediate Similarity NPD5330 Approved
0.7449 Intermediate Similarity NPD5205 Approved
0.7449 Intermediate Similarity NPD7334 Approved
0.7449 Intermediate Similarity NPD7521 Approved
0.7449 Intermediate Similarity NPD4688 Approved
0.7449 Intermediate Similarity NPD7146 Approved
0.7449 Intermediate Similarity NPD6409 Approved
0.7449 Intermediate Similarity NPD4138 Approved
0.7449 Intermediate Similarity NPD4693 Phase 3
0.7449 Intermediate Similarity NPD4689 Approved
0.7447 Intermediate Similarity NPD6929 Approved
0.7447 Intermediate Similarity NPD4195 Approved
0.7431 Intermediate Similarity NPD5128 Approved
0.7431 Intermediate Similarity NPD7320 Approved
0.7423 Intermediate Similarity NPD3668 Phase 3
0.7407 Intermediate Similarity NPD4767 Approved
0.7407 Intermediate Similarity NPD4768 Approved
0.7404 Intermediate Similarity NPD6084 Phase 2
0.7404 Intermediate Similarity NPD7902 Approved
0.7404 Intermediate Similarity NPD6083 Phase 2
0.7391 Intermediate Similarity NPD6942 Approved
0.7391 Intermediate Similarity NPD7339 Approved
0.7387 Intermediate Similarity NPD5217 Approved
0.7387 Intermediate Similarity NPD5216 Approved
0.7387 Intermediate Similarity NPD5127 Approved
0.7387 Intermediate Similarity NPD5215 Approved
0.7374 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6930 Phase 2
0.7368 Intermediate Similarity NPD7525 Registered
0.7368 Intermediate Similarity NPD6009 Approved
0.7368 Intermediate Similarity NPD6931 Approved
0.7368 Intermediate Similarity NPD7514 Phase 3
0.734 Intermediate Similarity NPD7145 Approved
0.734 Intermediate Similarity NPD3617 Approved
0.7339 Intermediate Similarity NPD5701 Approved
0.7328 Intermediate Similarity NPD6054 Approved
0.73 Intermediate Similarity NPD6903 Approved
0.73 Intermediate Similarity NPD6672 Approved
0.73 Intermediate Similarity NPD5737 Approved
0.73 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6902 Approved
0.729 Intermediate Similarity NPD7632 Discontinued
0.7283 Intermediate Similarity NPD4687 Approved
0.7283 Intermediate Similarity NPD5733 Approved
0.7281 Intermediate Similarity NPD6868 Approved
0.7264 Intermediate Similarity NPD6404 Discontinued
0.7255 Intermediate Similarity NPD7637 Suspended
0.7248 Intermediate Similarity NPD6008 Approved
0.7234 Intermediate Similarity NPD6925 Approved
0.7234 Intermediate Similarity NPD5776 Phase 2
0.7232 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD6370 Approved
0.7193 Intermediate Similarity NPD5167 Approved
0.7188 Intermediate Similarity NPD7332 Phase 2
0.7188 Intermediate Similarity NPD4695 Discontinued
0.7182 Intermediate Similarity NPD6412 Phase 2
0.7179 Intermediate Similarity NPD6319 Approved
0.7172 Intermediate Similarity NPD1696 Phase 3
0.7172 Intermediate Similarity NPD1694 Approved
0.717 Intermediate Similarity NPD5696 Approved
0.717 Intermediate Similarity NPD5290 Discontinued
0.7158 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7157 Intermediate Similarity NPD4096 Approved
0.7157 Intermediate Similarity NPD5207 Approved
0.7155 Intermediate Similarity NPD6335 Approved
0.7143 Intermediate Similarity NPD6695 Phase 3
0.7143 Intermediate Similarity NPD4691 Approved
0.7143 Intermediate Similarity NPD7604 Phase 2
0.7143 Intermediate Similarity NPD4747 Approved
0.7129 Intermediate Similarity NPD4518 Approved
0.7128 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD6015 Approved
0.7119 Intermediate Similarity NPD6016 Approved
0.7119 Intermediate Similarity NPD5983 Phase 2
0.7115 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD7900 Approved
0.7097 Intermediate Similarity NPD6926 Approved
0.7097 Intermediate Similarity NPD6924 Approved
0.7094 Intermediate Similarity NPD7101 Approved
0.7094 Intermediate Similarity NPD7100 Approved
0.7087 Intermediate Similarity NPD8034 Phase 2
0.7087 Intermediate Similarity NPD8035 Phase 2
0.7083 Intermediate Similarity NPD7492 Approved
0.7071 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD6317 Approved
0.7065 Intermediate Similarity NPD5276 Approved
0.7065 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7152 Approved
0.7065 Intermediate Similarity NPD7150 Approved
0.7065 Intermediate Similarity NPD7151 Approved
0.7059 Intermediate Similarity NPD5988 Approved
0.7053 Intermediate Similarity NPD6932 Approved
0.7048 Intermediate Similarity NPD5695 Phase 3
0.7034 Intermediate Similarity NPD6059 Approved
0.7033 Intermediate Similarity NPD4137 Phase 3
0.703 Intermediate Similarity NPD3573 Approved
0.7025 Intermediate Similarity NPD6336 Discontinued
0.7025 Intermediate Similarity NPD6616 Approved
0.7021 Intermediate Similarity NPD3703 Phase 2
0.7021 Intermediate Similarity NPD8264 Approved
0.7019 Intermediate Similarity NPD5133 Approved
0.7019 Intermediate Similarity NPD5778 Approved
0.7019 Intermediate Similarity NPD5779 Approved
0.701 Intermediate Similarity NPD8259 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data